Article content
Vancouver, British Columbia–(Newsfile Corp. – April 30, 2021) – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) (“
Veritas” or the “
Company“) is pleased to announce the results of its Annual and Special Meeting of the Shareholders (the “
Meeting“) held on April 29
th, 2021. At the Meeting, shareholders approved the acquisition of Indigenous Bloom Hemp Corporation (“
HempCo“) by special resolution. Details of the acquisition are in the Company’s Information Circular dated March 1, 2021, the amendment thereto dated March 24, 2021 and in the Company’s news release dated September 9, 2020. The acquisition also received minority approval of shareholders pursuant to the provisions of Multilateral Instrument 61-101
Vancouver, British Columbia (Newsfile Corp. - April 30, 2021) - Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") is pleased to announce the results of its Annual and
(2)
Vancouver, British Columbia (Newsfile Corp. - December 23, 2020) -
Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VPA) ( Veritas or the Company ) is pleased to announce that it expects to complete the Due Diligence process for the acquisition of Indigenous Bloom Hemp Corporation ( HempCo ) within the first half of January 2021 and announce the dates and process by which the shareholders will have an opportunity to approve the completion of this transaction.
Veritas interim CEO and CFO, Mr. Peter McFadden, commented, It has been a taxing few months, we have now nearly completed an extensive audit of HempCo and are more certain now than before that this transaction will provide our shareholders with substantial value.